Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Antai Pharmaceutical is a comprehensive pharmaceutical enterprise based in China, specializing in the research, development, and manufacturing of modern traditional Chinese medicine (TCM) and chemical drugs. The company is recognized as a National High-tech Enterprise and operates a National Enterprise Technology Center focused on cardiovascular and cerebrovascular health. Its product portfolio includes widely used treatments such as Ginkgo Biloba extract and Compound Salvia Miltiorrhiza tablets, alongside various chemical generics. Sichuan Antai Pharmaceutical maintains large-scale GMP-certified manufacturing facilities and is a key player in the regional pharmaceutical industry in Sichuan province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antai Pharmaceutical.